NSE filing, NSE: ARISTO. Summary written from the filing by ALFA Finder's alert engine.
Aristo Bio-Tech and Lifescience Ltd: key numbers
- Share price
- ₹86.00
- Market cap
- ₹58.55 Cr
- Revenue (annual)
- ₹363.7 Cr
- Net profit (annual)
- ₹7.18 Cr
- P/E (TTM)
- 8.2×Sector 34.1×
- Promoter holding
- 73.42%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aristo Bio-Tech and Lifescience Ltd
All →Aristo Bio-Tech and Lifescience Annual General Meeting
Aristo Bio-Tech and Lifescience Limited conducted its 21st Annual General Meeting on September 30, 2026. Shareholders considered and voted on routine items including financial statements and director appointments.
Aristo Bio-Tech and Lifescience Annual General Meeting
Aristo Bio-Tech and Lifescience Limited has issued a notice for its 21st Annual General Meeting to be held on September 30, 2026.
Aristo Bio-Tech and Lifescience Board Meeting Outcome
Aristo Bio-Tech declared a final dividend of Rs. 0.60 per share and approved re-appointments for directors and the cost auditor.
Aristo Bio-Tech and Lifescience H2 FY26 Results: Turns Profitable, Net Profit ₹3 Cr
Aristo Bio-Tech and Lifescience Ltd reported revenue from operations of ₹107.3 Cr (+3.3% YoY) and net profit of ₹3 Cr for H2 FY26.
- Key figure
- Net profit ₹3 Cr
Aristo Bio-Tech and Lifescience Financial Results
Aristo Bio-Tech approved audited FY26 financial results and recommended a final dividend of ₹0.60 per share. The results showed strong annual performance with unmodified audit opinions.
Aristo Bio-Tech and Lifescience Other Announcement
Aristo Bio-Tech submitted its annual SDD compliance certificate for FY 2025-26. The certificate confirms maintenance of the mandatory structured digital database for insider trading monitoring.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.